Summary: Metabolism boosters carry significant safety concerns, including cardiovascular risks, liver damage, and product contamination, with only modest and temporary metabolic effects
The most common adverse reactions for Wegovy (incidence 5%) in adults or pediatric patients aged 12 years and older are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia in patients with type 2 diabetes, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss
Independently tested at 99.07% purity by ILS Laboratories (San Diego, ISO/IEC 17025 accredited) via a full QC panel including heavy metals and sterility testing
Tirzepatide overcomes these limitations by simultaneously activating both GIPR and GLP-1R, thereby harnessing their complementary mechanisms of action [25]
Semaglutide works in several ways , including decreasing appetite, improving the way your body creates and circulates insulin, and slowing gastric emptying
However, researchers haven't tested this unofficial use of Wegovy to the same rigorous standards as the clinical dosing schedule, and it may not be safe